Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 36Completed 13Active not recruiting 13Terminated 7Not yet recruiting 5Unknown 4Withdrawn 3

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Melanoma 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Stomach Neoplasms 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Merkel Cell 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Small Cell Lung Cancer Recurrent 1Safety Issues 1Recurrent Liver Cancer After Liver Transplantation 1Recurrence 1Radiation Pneumonitis 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Lymphoma 1Lung Neoplasms 1Locally Advanced or Metastatic Solid Tumors 1Liver Neoplasms 1Kidney Neoplasms 1Hodgkin Disease 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × atezolizumab × Clear all
NCT05173298 2024-02-07

HCC

CHA University

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05886465 2023-06-02

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Jules Bordet Institute

Phase 2 Unknown
441 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT05396937 2022-05-31

Efficacy and Safety of T+A+RAD in HCC

Fudan University

Phase 2 Unknown
42 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡